{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T03:49:53Z","timestamp":1777952993485,"version":"3.51.4"},"reference-count":136,"publisher":"Informa UK Limited","issue":"5","funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82060623"],"award-info":[{"award-number":["82060623"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Therapeutic Patents"],"published-print":{"date-parts":[[2026,5,4]]},"DOI":"10.1080\/13543776.2026.2660906","type":"journal-article","created":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T15:08:56Z","timestamp":1776265736000},"page":"401-433","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Activin receptor-like kinase 5 (ALK5) inhibitors: a patent review (2013-present)"],"prefix":"10.1080","volume":"36","author":[{"given":"Xin-Yi","family":"Huang","sequence":"first","affiliation":[{"name":"Yanbian University","place":["Yanji, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao-Qun","family":"Yu","sequence":"additional","affiliation":[{"name":"Yanbian University","place":["Yanji, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Wang","sequence":"additional","affiliation":[{"name":"Yanbian University","place":["Yanji, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen","family":"Guo","sequence":"additional","affiliation":[{"name":"Yanbian University","place":["Yanji, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng-Hua","family":"Jin","sequence":"additional","affiliation":[{"name":"Yanbian University","place":["Yanji, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2026,4,19]]},"reference":[{"key":"e_1_3_6_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41580-018-0007-0"},{"key":"e_1_3_6_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01764-w"},{"key":"e_1_3_6_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2020.07.009"},{"key":"e_1_3_6_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2020.112154"},{"key":"e_1_3_6_7_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-101921-045939"},{"key":"e_1_3_6_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-020-0403-1"},{"key":"e_1_3_6_9_1","doi-asserted-by":"publisher","DOI":"10.1186\/s43556-022-00109-9"},{"key":"e_1_3_6_10_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-022-01349-6"},{"key":"e_1_3_6_11_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-020-00436-9"},{"key":"e_1_3_6_12_1","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20194188"},{"key":"e_1_3_6_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/emmm.201302524"},{"key":"e_1_3_6_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2022.128552"},{"key":"e_1_3_6_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2024.116395"},{"key":"e_1_3_6_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11030-024-10973-y"},{"key":"e_1_3_6_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/ardp.202400131"},{"key":"e_1_3_6_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2024.116311"},{"key":"e_1_3_6_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2025.114472"},{"key":"e_1_3_6_20_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.chemrestox.5c00036"},{"key":"e_1_3_6_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2023.109382"},{"key":"e_1_3_6_22_1","doi-asserted-by":"publisher","DOI":"10.2174\/1573406417666210628144849"},{"key":"e_1_3_6_23_1","doi-asserted-by":"publisher","DOI":"10.3390\/v14061308"},{"key":"e_1_3_6_24_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12929-021-00770-2"},{"key":"e_1_3_6_25_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13550-023-00966-7"},{"key":"e_1_3_6_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharep.2017.01.024"},{"key":"e_1_3_6_27_1","unstructured":"Yaozh [Internet]. Chongqing: Chongqing Kangzhou Tech & Trade Co. Ltd.; [cited 2024 Jul 26]. Available from: https:\/\/www.yaozh.com\/"},{"key":"e_1_3_6_28_1","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S86621"},{"key":"e_1_3_6_29_1","doi-asserted-by":"publisher","DOI":"10.14309\/ctg.0000000000000056"},{"key":"e_1_3_6_30_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-018-0246-z"},{"key":"e_1_3_6_31_1","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-002068"},{"key":"e_1_3_6_32_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm500115w"},{"key":"e_1_3_6_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2018.08.028"},{"key":"e_1_3_6_34_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10637-019-00835-y"},{"key":"e_1_3_6_35_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-019-03979-z"},{"key":"e_1_3_6_36_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-021-01053-x"},{"key":"e_1_3_6_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2022.115905"},{"key":"e_1_3_6_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2020.112354"},{"key":"e_1_3_6_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2025.118045"},{"key":"e_1_3_6_40_1","doi-asserted-by":"publisher","DOI":"10.3390\/ph18050716"},{"key":"e_1_3_6_41_1","unstructured":"Lee JY Ryu KH Kim JS et al. Inventors; sk Chemicals Co. Ltd. assignee. 2-pyridyl substituted imidazoles as ALK5 and\/or ALK4 inhibitors. World organization patent WO 2013009140. 2013 Jan 17."},{"key":"e_1_3_6_42_1","unstructured":"Jonczyk A Zenke FT Amendt C. Inventors; Merck patent Gmbh assignee. 7-azaindol-2 7-naphthyridine derivative for the treatment of tumors. World organization patent WO 2014053208. 2014 Apr 10."},{"key":"e_1_3_6_43_1","unstructured":"Dorsch D Jonczyk A Krier M. Inventors; Merck patent Gmbh assignee. 3-(1H-benzimidazol-2-yl)1H-pyridin-2-one derivatives. World organization patent WO 2016165808. 2016 Oct 20."},{"key":"e_1_3_6_44_1","unstructured":"Yan M Wang H Wang B et al. Inventors; China Pharmaceutical University assignee. Preparation of activin receptor-like kinase 5 inhibitors from dicaffeoylquinic acid derivatives. China patent CN 104434897. 2015 Mar 25."},{"key":"e_1_3_6_45_1","unstructured":"Wen XA Wu GQ Sun HB et al. Inventors; China Pharmaceutical University assignee. Imidazole-2-methylamine derivatives and their pharmaceutical uses. China patent CN 114380823. 2022 Apr 22."},{"key":"e_1_3_6_46_1","unstructured":"Xue XW Li QQ Yang YS et al. Inventors; China Pharmaceutical University assignee. Indazole-based ALK5 inhibitors and methods of preparation and use thereof. China patent CN 117186066. 2023 Dec 08."},{"key":"e_1_3_6_47_1","unstructured":"Beight DW Coates DA Joseph S et al. Inventors; Eli Lilly and Company assignee. Aminopyridyloxypyrazole compounds. World organization patent WO 2016057278. 2016 Apr 14."},{"key":"e_1_3_6_48_1","unstructured":"Fink BE Zhao YF Borzilleri RM et al. Inventors; Bristol-Myers Squibb Company assignee. TGF\u03b2 receptor antagonists. World organization patent WO 2016106266. 2016 Jun 30."},{"key":"e_1_3_6_49_1","unstructured":"Harikrishnan LS Fink BE Borzilleri RM et al. Inventors; Bristol-Myers Squibb Company assignee. TGF beta receptor antagonists. World organization patent WO 2017015425. 2017 Jan 26."},{"key":"e_1_3_6_50_1","unstructured":"Borzilleri RM Fink BE Harikrishnan LS et al. Inventors; Bristol-Myers Squibb Company assignee. TGF beta receptor antagonists. World organization patent WO 2017040448. 2017 Mar 09."},{"key":"e_1_3_6_51_1","unstructured":"Harikrishnan LS Fink BE Borzilleri RM et al. Inventors; Bristol-Myers Squibb Company assignee. TGF beta receptor antagonists. World organization patent WO 2017019757. 2017 Feb 02."},{"key":"e_1_3_6_52_1","unstructured":"Borzilleri RM Fink BE Harikrishnan LS et al. Inventors; Bristol-Myers Squibb Company assignee. TGF beta receptor antagonists. World organization patent WO 2017035118. 2017 Mar 02."},{"key":"e_1_3_6_53_1","unstructured":"Sun F Wu LF Ding CZ et al. Inventors; Medshine discovery Inc. assignee. Benzotriazole-derived \u0391 and \u0392 unsaturated amide compound used as TGF-\u0392RI inhibitor. World organization patent WO 2017215506. 2017 Dec 21."},{"key":"e_1_3_6_54_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.8b01153"},{"key":"e_1_3_6_55_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-25-0085"},{"key":"e_1_3_6_56_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.730666"},{"key":"e_1_3_6_57_1","unstructured":"Fu XY Ding CZ Hu LH et al. Inventors; Medshine discovery Inc. assignee. Double pyrazole compound as TGF-\u03b2RI kinase inhibitor. World organization patent WO 2020088526. 2020 May 07."},{"key":"e_1_3_6_58_1","doi-asserted-by":"publisher","DOI":"10.1002\/j.1460-2075.1995.tb07214.x"},{"key":"e_1_3_6_59_1","unstructured":"Fu XY Ding CZ Hu LH et al. Inventors; Medshine discovery Inc. assignee. 5-(4-pyridyloxy)pyrazole compounds serving as TGF-\u03b2RI kinase inhibitor. World organization patent WO 2020151749. 2020 Jul 30."},{"key":"e_1_3_6_60_1","unstructured":"Lee KI Jung YH Song JY et al. Inventors; Hanmi Pharmaceutical Co. Ltd. assignee. Novel pyrazole derivative as ALK5 inhibitor and uses thereof. World organization patent WO 2018004290. 2018 Jan 04."},{"key":"e_1_3_6_61_1","unstructured":"Xu ZS Lou YT Chen L. Inventors; Shanghai Yingli Pharmaceutical Co. Ltd. assignee. Nitrogenous heterocyclic aromatic compound preparation method therefor pharmaceutical composition thereof and application thereof. World organization patent WO 2018019106. 2018 Feb 01."},{"key":"e_1_3_6_62_1","unstructured":"Xu ZS Lou YT Chen L et al. Inventors; Shanghai Yingli Pharmaceutical Co. Ltd. assignee. Aromatic heterocyclic compound intermediate thereof preparation method therefor and pharmaceutical composition and use thereof. World organization patent WO 2019144764. 2019 Aug 01."},{"key":"e_1_3_6_63_1","unstructured":"Xu ZS Lou YT Chen L et al. Inventors; Shanghai Yingli Pharmaceutical Co. Ltd. assignee. Aromatic heterocyclic substituted olefin compound preparation method for same pharmaceutical composition of same and applications thereof. World organization patent WO 2019144765. 2019 Aug 01."},{"key":"e_1_3_6_64_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2021.39.15_suppl.3098"},{"key":"e_1_3_6_65_1","unstructured":"Yu SH Yang FL Yan JJ et al. Inventors; Jiangsu Hengrui medicine Co. Ltd. assignee. Five-membered heteroaryl ring bridged ring derivative preparation method therefor and medical use thereof. World organization patent WO 2018068759. 2018 Apr 19."},{"key":"e_1_3_6_66_1","unstructured":"Yang FL Zhang L Shen GY et al. Inventors; Jiangsu Hengrui medicine Co. Ltd. assignee. 3 4-bipyridyl pyrazole derivative and preparation method therefor and medical application thereof. World organization patent WO 2018086609. 2018 May 17."},{"key":"e_1_3_6_67_1","unstructured":"Yang FL Zhang L He F et al. Inventors; Jiangsu Hengrui medicine Co. Ltd. assignee. 6-pyrazole-[1 2 4]triazolo[4 3-a]pyridine-3-amide derivative preparation method therefor and use thereof in medicine. World organization patent WO 2018171611. 2018 Sep 27."},{"key":"e_1_3_6_68_1","unstructured":"Yang FL Shen GY Han JH et al. Inventors; Jiangsu Hengrui medicine Co. Ltd. assignee. 3-pyridinyl-4-benzothiazolyl pyrazole derivatives preparation method therefor and use thereof in medicine. China patent CN 108069955. 2018 May 25."},{"key":"e_1_3_6_69_1","unstructured":"Sawyer JS. Inventor; Clavius Pharmaceuticals LLC assignee. Tri-substituted imidazoles for the inhibition of TGF beta and methods of treatment. World organization patent WO 2019005241. 2019 Jan 03."},{"key":"e_1_3_6_70_1","unstructured":"Sawyer JS. Inventor; Clavius Pharmaceuticals LLC assignee. Substituted imidazoles for the inhibition of TGF-beta and methods of treatment. World organization patent WO 2020041562. 2020 Feb 27."},{"key":"e_1_3_6_71_1","unstructured":"Smith SW Coburn CA Dubose RF. Inventors; Silverback Therapeutics Inc. assignee. ALK5 inhibitors conjugates and uses thereof. World organization patent WO 2019195278. 2019 Oct 10."},{"key":"e_1_3_6_72_1","unstructured":"Smith SW Coburn CA Baum PR et al. Inventors; Silverback Therapeutics Inc. assignee. ALK5 inhibitors conjugates and uses thereof. World organization patent WO 2021011834. 2021 Jan 21."},{"key":"e_1_3_6_73_1","unstructured":"Smith SW Baum PR Dubose R et al. Inventors; Silverback Therapeutics Inc. assignee. ALK5 inhibitors conjugates and uses thereof. World organization patent WO 2022006340. 2022 Jan 06."},{"key":"e_1_3_6_74_1","unstructured":"Smith SW Hunt KW. Inventors; Silverback Therapeutics Inc. assignee. ALK5 inhibitors conjugates and uses thereof. World organization patent WO 2022076905. 2022 Apr 14."},{"key":"e_1_3_6_75_1","unstructured":"Bearss DJ Warner SL. Inventors; Tolero Pharmaceuticals Inc. assignee. ALK5 inhibitors for treating myelodysplastic syndrome. World organization patent WO 2020146819. 2020 Jul 16."},{"key":"e_1_3_6_76_1","unstructured":"Pujala B Pendharkar D Agarwal AK et al. Inventors; Integral Biosciences Pvt. Ltd. assignee. Heterocyclic compounds and methods of use. World organization patent WO 2020012357. 2020 Jan 16."},{"key":"e_1_3_6_77_1","unstructured":"Wu TY Jin Q. Inventors; Nexys Therapeutics Inc. assignee. (pyridin-2-yl)amine derivatives as TGF-betaRI (ALK5) inhibitors for the treatment of cancer. World organization patent WO 2020139636. 2020 Jul 02."},{"key":"e_1_3_6_78_1","unstructured":"Wang Y Zhao LW Wang YZ et al. Inventors; Nanjing Sanhome Pharmaceutical Co. Ltd. assignee. Compound as TGF-\u03b2 r\u2170 inhibitor and application thereof. World organization patent WO 2020078402. 2020 Apr 23."},{"key":"e_1_3_6_79_1","unstructured":"Wang Y Zhao LW Wang YZ et al. Inventors; Nanjing Sanhome Pharmaceutical Co. Ltd. assignee. TGF-\u03b2RI inhibitor and use thereof. World organization patent WO 2020103817. 2020 May 28."},{"key":"e_1_3_6_80_1","unstructured":"Wu XK Ma HY Li MX et al. Inventors; Zhongke Lijian Pharmaceutical (Guangzhou) Co. Ltd. assignee. 2-aryl-4-(4-pyrazolyloxy)pyridine analogs methods for their preparation pharmaceutical compositions and applications. China patent CN 111116565. 2020 May 08."},{"key":"e_1_3_6_81_1","unstructured":"Wu XK He C Ma HY et al. Inventors; Zhongke Lijian Pharmaceutical (Guangzhou) Co. Ltd. assignee. 4-(4-pyrazolyloxy)quinoline analogs methods for their preparation pharmaceutical compositions and applications. China patent CN 111303135. 2020 Jun 19."},{"key":"e_1_3_6_82_1","unstructured":"Xu DF He C Lei QS et al. Inventors; Zhongke Lijian Pharmaceutical (Guangzhou) Co. Ltd. assignee. Nitrogen-containing heterocyclic organic compounds and their preparation methods and applications. China patent CN 111269215. 2020 Jun 12."},{"key":"e_1_3_6_83_1","unstructured":"Seo J Kim M Han C et al. Inventors; Bisichem Co. Ltd. assignee. A fused ring heteroaryl compound as an ALK4\/5 inhibitor. World organization patent WO 2020153676. 2020 Jul 30."},{"key":"e_1_3_6_84_1","unstructured":"Seo J Han C Yoon C et al. Inventors; Bisichem Co. Ltd. assignee. Fused ring heteroaryl compounds and use thereof. World organization patent WO 2023018313. 2023 Feb 16."},{"key":"e_1_3_6_85_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2023.129205"},{"key":"e_1_3_6_86_1","unstructured":"Jin XJ Jin CH Guo Z et al. Inventors; Yanbian University assignee. Imidazole derivatives containing indazole structures and methods of preparation and applications thereof. China patent CN 112266378. 2021 Jan 26."},{"key":"e_1_3_6_87_1","unstructured":"Jin CH Nan JX Lian LH. Inventors; Yanbian University assignee. Application of a pyrazole derivative containing pyridine structure in the preparation of anti-hepatic fibrosis drugs. China patent CN 113876769. 2022 Jan 04."},{"key":"e_1_3_6_88_1","unstructured":"Jin CH Lian LH Nan JX et al. Inventors; Yanbian University assignee. Imidazole and thiazole derivatives containing amino acid structures and methods of preparation and applications thereof. China patent CN 115466260. 2022 Dec 13."},{"key":"e_1_3_6_89_1","unstructured":"Jin CH Wu YL Yang YX. Inventors; Yanbian University assignee. An amide derivative containing an imidazole structure and its preparation method and application. China patent CN 116891472. 2023 Oct 17."},{"key":"e_1_3_6_90_1","unstructured":"Jin CH Lian LH Nan JX et al. Inventors; Yanbian University assignee. An ALK5 kinase inhibitor its preparation method and application. China patent CN 120004889. 2025 May 16."},{"key":"e_1_3_6_91_1","unstructured":"Chen SJ Song S Zhang YT et al. Inventors; Sichuan Kelun Botai Biomedicine Co. Ltd.assignee. Pyrazoloids pharmaceutical compositions comprising the same methods of preparation thereof and uses thereof. China patent CN 112694477. 2021 Apr 23."},{"key":"e_1_3_6_92_1","unstructured":"Yang G Huang HL Wei MM et al. inventors; Nankai University assignee. A 4-aminopyrazolo[3 4-d]pyrimidine derivative and its application. China patent CN 113264937. 2021 Aug 17."},{"key":"e_1_3_6_93_1","unstructured":"Stover D Bharali D Hay BA et al. Inventors; Nammi Therapeutics Inc. assignee. Formulated and\/or co-formulated liposome compositions containing TGFb antagonist prodrugs useful in the treatment of cancer and methods thereof. World organization patent WO 2021167703. 2021 Aug 26."},{"key":"e_1_3_6_94_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm0509905"},{"key":"e_1_3_6_95_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.9b00708"},{"key":"e_1_3_6_96_1","unstructured":"Tanaka K. Inventor; Alchemedicine Inc. assignee. Heterocyclic compound as inhibitor for casein kinase 1\u03b4 and\/or activin receptor-like kinase 5. World organization patent WO 2021261544. 2021 Dec 30."},{"key":"e_1_3_6_97_1","unstructured":"Yu ZY Li G Shi YQ et al. Inventors; Adlai Nortye Biopharma Co. Ltd. assignee. TGF-\u03b2 receptor inhibitor. China patent CN 112707902. 2021 Apr 27."},{"key":"e_1_3_6_98_1","unstructured":"Yu ZY Li G Wang KY et al. Inventors; Adlai Nortye Biopharma Co. Ltd. assignee. Transforming growth factor-\u03b2 receptor inhibitor. World organization patent WO 2021190425. 2021 Sep 30."},{"key":"e_1_3_6_99_1","unstructured":"Yang AL Ji S Wang H et al. Inventors; Brilliant Pharmaceutical Co. Ltd. assignee. Transforming growth factor receptor antagonists methods of preparation thereof and applications thereof. China patent CN 113620956. 2021 Nov 09."},{"key":"e_1_3_6_100_1","unstructured":"Yang AL Ji S Wang H et al. Inventors; Brilliant Pharmaceutical Co. Ltd. assignee. Transforming growth factor receptor antagonists methods of preparation thereof and applications thereof. China patent CN 113698395. 2021 Nov 26."},{"key":"e_1_3_6_101_1","unstructured":"Bosser-Artal R Pampin-Casal B Palomino-Laria JC. Inventors; Origo Biopharma S.L. assignee. Benzylamide derivatives as inhibitors of transforming growth factor-beta receptor I\/ALK5. World organization patent WO 2021105317. 2021 Jun 03."},{"key":"e_1_3_6_102_1","unstructured":"Bosser-Artal R Pampin-Casal B Castro-Palomino-Laria J. Inventors; Origo Biopharma S.L. assignee. 2-(3-pyridin-2-yl-4-quinolin-4-yl-pyrazol-l-yl)- acetamide derivatives as inhibitors of transforming growth factor-beta receptor I\/ALK5. World organization patent WO 2021069509. 2022 Apr 07."},{"key":"e_1_3_6_103_1","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjae190.0508"},{"key":"e_1_3_6_104_1","unstructured":"Tang F Jin GH Wu QP et al. Inventors; Jiangsu Simcere Pharmaceutical Co. Ltd. assignee. Pyrazole compounds. World organization patent WO 2021129621. 2021 Jul 01."},{"key":"e_1_3_6_105_1","unstructured":"Jin GH Wu QP Zhang K et al. Inventors; Jiangsu Simcere Pharmaceutical Co. Ltd. assignee. Quinoline compounds. China patent CN 114437082. 2022 May 06."},{"key":"e_1_3_6_106_1","unstructured":"Owens C Kulyk S Sullivan SDE et al. Inventors; Theravance Biopharma R&D IP LLC assignee. Substituted 1 5-naphthyridines or quinolines as ALK5 inhibitors. World organization patent WO 2021102468. 2021 May 27."},{"key":"e_1_3_6_107_1","unstructured":"Loo M Kulyk S Bailey C et al. Inventors; Theravance Biopharma R&D IP LLC assignee. Substituted pyrimidines and methods of use. World organization patent WO 2021203131. 2021 Oct 07."},{"key":"e_1_3_6_108_1","unstructured":"Brozell A Dabros M Fu J et al. Inventors; Theravance Biopharma R&D IP LLC assignee. Naphthyridine derivatives useful as ALK5 inhibitors. World organization patent WO 2021253041. 2021 Dec 16."},{"key":"e_1_3_6_109_1","unstructured":"Owens C Sullivan SDE Allegretti P et al. Inventors; Theravance Biopharma R&D IP LLC assignee. Bicyclic inhibitors of ALK5 and methods of use. World organization patent WO 2022251359. 2022 Dec 01."},{"key":"e_1_3_6_110_1","unstructured":"Fu XY Li XT Hu LH et al. Inventors; Jiangsu Aosaikang Pharmaceutical Co. Ltd. assignee. Salt form and crystal form of pyridyloxy pyrazole compound as TGF-\u03b2r1 inhibitor and pharmaceutical composition thereof. World organization patent WO 2022017208. 2022 Jan 27."},{"key":"e_1_3_6_111_1","unstructured":"Zou QA Zhang JC Chen YW et al. Inventors; Guangzhou Henovcom Bioscience Co. Ltd. assignee. Imidazole compound pharmaceutical composition thereof and use thereof. World organization patent WO 2022184000. 2022 Sep 09."},{"key":"e_1_3_6_112_1","unstructured":"Bullough DA Foulkes JG Beeley NR et al. Inventors; Thirona Bio Inc. assignee. Methods for treating a pulmonary disease with an ALK-5 (TGF beta r\u2170) inhibitor. World organization patent WO 2022235621. 2022 Nov 10."},{"key":"e_1_3_6_113_1","unstructured":"Liu MM Meng XM Li T et al. Inventors; Anhui medical University assignee. A diarylpyrimidine amide compound or a pharmaceutically acceptable salt thereof pharmaceutical compositions and applications thereof. China patent CN 115340497. 2022 Nov 15."},{"key":"e_1_3_6_114_1","unstructured":"Franz B Siddiqui-Jain A Warner SL et al. Inventors; Sumitomo Pharma oncology Inc. assignee. ALK-5 inhibitors and uses thereof. World organization patent WO 2022126133. 2022 Jun 16."},{"key":"e_1_3_6_115_1","unstructured":"Franz B Siddiqui-Jain A Warner SL. Inventors; Sumitomo Pharma oncology Inc. assignee. ALK-5 inhibitors and uses thereof. World organization patent WO 2022204721. 2022 Sep 29."},{"key":"e_1_3_6_116_1","unstructured":"Pala D Pizzirani D Bruno P et al. Inventors; Chiesi Farmaceutici S.P.A. assignee. Pyrido oxazine derivatives as ALK5 inhibitors. World organization patent WO 2022013311. 2022 Jan 20."},{"key":"e_1_3_6_117_1","unstructured":"Pala D Pizzirani D Bruno P et al. Inventors; Chiesi Farmaceutici S.P.A. assignee. Pyrido oxazine amino derivatives as ALK5 inhibitors. World organization patent WO 2022013312. 2022 Jan 20."},{"key":"e_1_3_6_118_1","unstructured":"Pala D Pizzirani D Bruno P et al. Inventors; Chiesi Farmaceutici S.P.A. assignee. Pyrido oxazine derivatives as ALK5 inhibitors. World organization patent WO 2022136221. 2022 Jun 30."},{"key":"e_1_3_6_119_1","unstructured":"Pizzirani D Ronchi P Guariento S et al. Inventors; Chiesi Farmaceutici S.P.A. assignee. Pyridazinyl amino derivatives as ALK5 inhibitors. World organization patent WO 2023046698. 2023 Mar 30."},{"key":"e_1_3_6_120_1","unstructured":"Pizzirani D Ronchi P Rescigno D. Inventors; Chiesi Farmaceutici S.P.A. assignee. Pyridazinyl amino derivatives as ALK5 inhibitors. World organization patent WO 2023135107. 2023 Jul 20."},{"key":"e_1_3_6_121_1","unstructured":"Pizzirani D Ronchi P Biagetti M et al. Inventors; Chiesi Farmaceutici S.P.A. assignee. Imidazole derivatives as ALK5 inhibitors. World organization patent WO 2023208986. 2023 Nov 02."},{"key":"e_1_3_6_122_1","unstructured":"Pala D Pizzirani D Guariento S et al. inventors; Chiesi Farmaceutici S.P.A. assignee. 5-(4-fluorophenyl)-2 3-dihydro-1H-imidazo[1 2-a]imidazole derivatives as alk inhibitors for the treatment of fibrosis. World organization patent WO 2023247592. 2023 Dec 28."},{"key":"e_1_3_6_123_1","unstructured":"Pala D Pizzirani D Ronchi P. Inventors; Chiesi Farmaceutici S.P.A. assignee. Pyrido oxazolidinone derivatives as ALK5 inhibitors. World organization patent WO 2024105070. 2024 May 23."},{"key":"e_1_3_6_124_1","unstructured":"Armani E Ronchi P Pizzirani D et al. Inventors; Chiesi Farmaceutici S.P.A. assignee. Pyridazinyl amino derivatives as ALK5 inhibitors. World organization patent WO 2025132458. 2025 Jun 26."},{"key":"e_1_3_6_125_1","unstructured":"Armani E Ronchi P Pizzirani D. Inventors; Chiesi Farmaceutici S.P.A. assignee. Pyridazinyl amino derivatives as ALK5 inhibitors. World organization patent WO 2025132460. 2025 Jun 26."},{"key":"e_1_3_6_126_1","unstructured":"Gao B Lu XL Wang HZ et al. Inventors; Shenyang Yujie Biotechnology Co. Ltd. assignee. Application of sanguinarine or plants containing sanguinarine or extracts thereof in the preparation of antipulmonary fibrosis drugs or foodstuffs. China patent CN 115837024. 2023 Mar 24."},{"key":"e_1_3_6_127_1","unstructured":"Lu L Zhao SS Zhang LZ et al. Inventors; Henan Medinno Pharmaceutical Technology Co. Ltd. assignee. TGF-\u03b2 inhibitor compound and use thereof. World organization patent WO 2024032598. 2024 Feb 15."},{"key":"e_1_3_6_128_1","unstructured":"Sawa M Arai M Hanada M et al. Inventors; Carna Biosciences Inc. assignee. Novel thiazole derivative. World organization patent WO 2024111626. 2024 May 30."},{"key":"e_1_3_6_129_1","unstructured":"Del-Pozo-Losada J Marcilla-D\u00edaz A Del-Pozo-Losada C et al. Inventors; Universitat de Val\u00e8ncia assignee. Derivatives of imidazo[1 2-a]pyridine with anti-inflammatory activity. World organization patent WO 2025003545. 2025 Jan 02."},{"key":"e_1_3_6_130_1","unstructured":"Hong YR Jo YK Park CH et al. Inventors; Autotelic Bio Inc. assignee. Composition for treating uterine fibrosis comprising thiazole derivative compound. World organization patent WO 2025063816. 2025 Mar 27."},{"key":"e_1_3_6_131_1","unstructured":"Hong YR Kim YS Park CH et al. Inventors; Autotelic Bio Inc. assignee. Composition for treating fibrotic disease comprising thiazole derivative compound. World organization patent WO 2025063819. 2025 Mar 27."},{"key":"e_1_3_6_132_1","unstructured":"Hong YR Park CH Kim JH et al. Inventors; Autotelic Bio Inc. assignee. Composition for treating pulmonary fibrosis comprising thiazole derivative compound. World organization patent WO 2025063820. 2025 Mar 27."},{"key":"e_1_3_6_133_1","unstructured":"Yuan L Huang HQ Wu HY et al. Inventors; Shenyang Pharmaceutical University assignee. Peptide-like bis-aryl substituted pyrazole compounds their preparation methods and applications. China patent CN 120441544. 2025 Aug 08."},{"key":"e_1_3_6_134_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.actbio.2021.07.051"},{"key":"e_1_3_6_135_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2021.113311"},{"key":"e_1_3_6_136_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2019.126822"},{"key":"e_1_3_6_137_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.fitote.2024.106052"},{"key":"e_1_3_6_138_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2024.107332"}],"container-title":["Expert Opinion on Therapeutic Patents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13543776.2026.2660906","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T13:47:52Z","timestamp":1777902472000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13543776.2026.2660906"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,19]]},"references-count":136,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5,4]]}},"alternative-id":["10.1080\/13543776.2026.2660906"],"URL":"https:\/\/doi.org\/10.1080\/13543776.2026.2660906","relation":{},"ISSN":["1354-3776","1744-7674"],"issn-type":[{"value":"1354-3776","type":"print"},{"value":"1744-7674","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,19]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ietp20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ietp20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-09-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-13","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-19","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}